Rockefeller Capital Management
EPZM

Rockefeller Capital Management’s Epizyme, Inc EPZM Stock Holding History

Rockefeller Capital Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-12,344
Closed -$198K – 2881
2020
Q2 		$198K Buy
+12,344
New +$215K ﹤0.01% 955
2020
Q1 		– Sell
-5
Closed – – 2528
2019
Q4 		$0 Buy
+5
New +$74 ﹤0.01% 2259
2019
Q3 		– Sell
-7,050
Closed -$88K – 2006
2019
Q2 		$88K Buy
+7,050
New +$90.7K ﹤0.01% 715

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Rockefeller Capital Management's EPZM Position: Q3 2020 in Review

Rockefeller Capital Management sold out of Epizyme, Inc (EPZM) in Q3 2020, closing a stake of 12,344 shares — an estimated $198K sold.

Rockefeller Capital Management first reported a position in EPZM in Q2 2019 and held it in 3 quarters. The position peaked at $198K in Q2 2020. 151 funds tracked by Wall St. Rank hold EPZM as of Q3 2020.

  • Rockefeller Capital Management reported no remaining Epizyme, Inc position as of Q3 2020 after selling out during the quarter.
  • Rockefeller Capital Management sold 12,344 Epizyme, Inc shares in Q3 2020, an estimated $198K.
  • Rockefeller Capital Management first reported a position in Epizyme, Inc in Q2 2019 and held it in 3 quarters.
  • Rockefeller Capital Management's Epizyme, Inc position peaked at $198K in Q2 2020.
  • 151 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2020.

Based on Rockefeller Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.